Low levels of Caspase-3 predict favourable response to 5FU-based chemotherapy in advanced colorectal cancer: Caspase-3 inhibition as a therapeutic approach

Colorectal cancer (CRC) is one of the most common cancers in the Western world. 5-Fluorouracil (5FU)-based chemotherapy (CT) remains the mainstay treatment of CRC in the advanced setting, and activates executioner caspases in target cells. Executioner caspases are key proteins involved in cell disas...

Descripción completa

Detalles Bibliográficos
Autores principales: Flanagan, L, Meyer, M, Fay, J, Curry, S, Bacon, O, Duessmann, H, John, K, Boland, K C, McNamara, D A, Kay, E W, Bantel, H, Schulze-Bergkamen, H, Prehn, J H M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4849164/
https://www.ncbi.nlm.nih.gov/pubmed/26844701
http://dx.doi.org/10.1038/cddis.2016.7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4849164/
https://www.ncbi.nlm.nih.gov/pubmed/26844701
http://dx.doi.org/10.1038/cddis.2016.7

Ejemplares similares